ABOUT CONFERENCE

Larix international is delighted to invite you to attend the Singapore International Neuroscience summit one of it remarkable conferences, to be held during JULY 25-26 , 2019 in Singapore. We are excited to offer a diverse schedule of workshops that explore the theme of relevant action for better health in Neuroscience.

This SINS-2019 conference includes a wide range of Keynote presentations, Oral talks, Poster presentations, Symposia, Workshops, Exhibitions and Career development programs.
Throughout the two day conference, you will have the opportunity to both network and hear leaders from the international academic and corporate pharma companies and neurology communities.

The conference sets the stage for the dissemination and exchange of new developments in diverse, hot fields within Clinical Psychology and Alzheimer disease, being the platform for inspiration, collaboration and networking for researchers in academia and industry.

Larix International is dedicated non-profit organization dedicated to building communities that advance the frontiers of science. Our conferences bring a global network of scientists together to discuss the latest pre-publication research in their fields.

Larix Conferences are a group of prestigious international scientific conferences organized by a nonprofit organization of the same name. The conference topics cover frontier research in the medical, life sciences and Engineering and their related technologies.

Why SINS-2019

The International Congress on Clinical Psychology and Alzheimer diseases a unique platform for academic and industrial experts in the world and is the flagship annual event. Your participation in Neurology 2019 will, amongst others, enable you to

  • The Neurology 2019 is an opportunity for health professionals in Neuroscience and Clinical Psychology disciplines to work together and advance our field.
  • The Neurology 2019 is where some of the best exchanges take place. Join your colleagues and clients to discuss innovative research and form new partnerships for vascular and cardiac care
  • The program is designed to provide a wide knowledge that will keep medical professionals alongside of the issues affecting the diagnosis, treatment of Neuro-disorders and prevention
  • Knowledge in implementing new strategies on a wide array of clini
  • Knowledge in implementing new strategies on a wide array of clini

WHY SINGAPORE

  • Singapore is ranked 6th in the WHO of the world’s health systems in 2018.
  • The Economist Intelligence Unit placed Singapore 2nd out of 166 countries for health-care outcomes.
  • Bloomberg Global Health Index ranked Singapore the 4th healthiest country in the world and first in Asia.
  • Singapore healthcare spending has risen from $4 billion in 2011 to $9.8 billion in 2016.
  • Approximately 70–80% of Singaporeans obtain their medical care within the public health system.
  • The World Bank ranked Singapore the second easiest place to do business in the world.
  • Singapore has the second lowest infant mortality in the world and the ninth highest life expectancy.
  • Singapore ranked second-most visited city in Asia-Pacific and fourth-most visited city in the world.